Social Acceptance of Nanomedicine by Subashi, Ergys David et al.
Worcester Polytechnic Institute
Digital WPI
Interactive Qualifying Projects (All Years) Interactive Qualifying Projects
March 2007
Social Acceptance of Nanomedicine
Ergys David Subashi
Worcester Polytechnic Institute
Katelyn M. Ryan
Worcester Polytechnic Institute
Nathalia Arenas
Worcester Polytechnic Institute
Follow this and additional works at: https://digitalcommons.wpi.edu/iqp-all
This Unrestricted is brought to you for free and open access by the Interactive Qualifying Projects at Digital WPI. It has been accepted for inclusion in
Interactive Qualifying Projects (All Years) by an authorized administrator of Digital WPI. For more information, please contact digitalwpi@wpi.edu.
Repository Citation
Subashi, E. D., Ryan, K. M., & Arenas, N. (2007). Social Acceptance of Nanomedicine. Retrieved from https://digitalcommons.wpi.edu/
iqp-all/2109
  
 
Social Acceptance of Nanomedicine 
 
 
AN INTERACTIVE QUALIFYING PROJECT 
 
submitted to the Faculty of the 
 
WORCESTER POLYTECHNIC INSTITUTE 
 
in partial fulfillment of the requirements for the 
 
Degree of Bachelor of Science 
 
by 
 
________________________________ 
Nathalia Arenas 
 
________________________________ 
Katelyn M. Ryan 
 
________________________________ 
Ergys Subashi 
 
Date: March 1, 2007 
 
 
 
 
 
 
 
 
________________________________ 
Dr. Nancy A. Burnham, Major Advisor 
  
i 
i 
ABSTRACT 
The social acceptance of nanomedicine was studied through a survey distributed 
to Worcester Polytechnic Institute students. There was no correlation between the 
acceptance of nanomedicine and the respondents’ cognitive types or their risk behavior. 
Nonetheless, a significant result for public-relations strategies of nanomedicine was that 
the most influential factors for using a new medicine were: doctor’s advice, clinical 
research, side effects, FDA approval of the medicine, information on package, and 
research journal.  
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1. CONTEXT AND GOALS  
1.1. INTRODUCTION 
The improvement of the quality of life in our society over the last few decades has 
been very closely related to the rapid development of technology. Many organizations 
use technological advance as the main criterion to judge the progress of the economy, 
thus determining the quality of people’s lives in different geographical regions. 
Nanotechnology is undoubtedly the newest and the most promising field of engineering 
applications in the western countries. Intense academic research over the last years 
coupled with industrial demand is making it possible for engineers to measure, observe, 
control, manipulate, and manufacture devices with dimensions between one and one-
hundred nanometers. These new techniques have the potential to radically revolutionize 
the way we fabricate and use new products.  
1.2. NANOTECHNOLOGY: TODAY’S EMERGING TECHNOLOGY 
However, as with all new technologies, nanotechnology contains an attendant risk. 
This risk factor has an immense influence on consumers’ mindsets, especially on their 
receptivity to nanomedicine, which is one of the areas of nanotechnology. The potential 
benefits of nanotechnology and nanomedicine cannot be fully studied without proper 
acceptance and funding from the scientific community and beyond. Therefore, a careful 
investigation is essential for understanding how people perceive the risks of these new 
fields and what can be done to change people’s decision-making processes.  
In 1959 the Nobel laureate physicist Richard Feynman presented a lecture which 
he entitled, “There’s Plenty of Room at the Bottom.” His ideas challenged the scientific 
community to think critically about unforeseen scientific discoveries and their potential 
applications. He believed that careful application of the laws of physics and chemistry 
would make it possible for engineers to design and manufacture devices with a technique 
that is today referred to as the “bottom-up”1 technique.  
This new approach would construct materials and devices molecule by molecule, 
giving us the ability of molecular manufacturing. The process would create new products 
                                                 
1 Editors of Scientific American, Understanding Nanotechnology, New York: Warner Books, 2002. 
  
2 
2 
by stacking molecules one by one and leaving no space for errors. In theory, with the 
bottom-up method, every entity that is built today could be reproduced by using 
standardized molecular manufacturing techniques2.  
The essential tool that will make molecular manufacturing possible is the 
assembler. An assembler is a device, like the milling machine and the lathe, which can 
construct products; it will be the quantum of manufacturing4. The existence of these 
assemblers will produce molecular devices with optimal accuracy. Furthermore, their use 
will reduce costs drastically since there is almost no need for human control as with 
current machinery. More importantly, toxic leftovers and polluters will be eliminated 
from the manufacturing process as assemblers create products from molecules.5  
Another approach for nanotechnology is termed self-assembly. It is well known 
that many molecules have a tendency to bind with each other because of their chemical 
affinities6 . It is also known that some structures are more stable than others. If the 
appropriate molecules are positioned correctly they will self-assemble similarly to a 
natural process.  
                                                 
2 Ratner,M. and Ratner D. Nanotechnology: A Gentle Introduction to the Next Big Idea. New Jersey: 
Prentice Hall, 2003.  
3 Picture taken from: http://pnewsimg.bbc.co.uk. 
4 Editors of Scientific American, Understanding Nanotechnology, New York: Warner Books, 2002 
5 Ibid. 
6 Ratner,M. and Ratner D. Nanotechnology: A Gentle Introduction to the Next Big Idea. New Jersey: 
Prentice Hall, 2003. 
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These techniques have had a major impact in the way scientists and engineers 
think about future innovations.  Nanotechnology promises a great future, not only in the 
way we create new applications, but also in the way we think about these revolutionary 
applications. This field has the potential to become the grand unifier of the applied 
sciences. From materials science to biomedical engineering, almost every industrial area 
will be affected by the applications of this new field. As a matter of fact, many companies 
are currently using nanodevices: IBM has a data storage device; Gilead Sciences has a 
drug delivery system7; Carbon Nanotechnologies has the best available technique for 
manufacturing raw materials, especially buckminsterfullerenes8. In the year 2000, under 
the Clinton administration, the United States government dedicated itself to the 
development of nanotechnology when the National Nanotechnology Initiative was 
created with a budget of $422 million9. Since then, funding and interest for research has 
increased enormously. In 2001 more than thirty nanotechnology research groups and 
centers were active in the field10. Nanotechnology has the potential for applications in 
various fields such as: national security, medicine, clothing, and the food industry. 
Furthermore, the spatial dimensions make this field suitable for the synthesis of most 
organic compounds. Hence, the development of nanotechnology will inevitably bring 
major advances in medicine and biology. 
1.3. NANOMEDICINE 
In fact, the application of nanotechnology to medicine is so broad that this new 
field has been given a term of its own. Nanomedicine aims at achieving medical benefits 
using nanotechnological applications through nanovaccinology, nanoparticle drug 
therapy, and biosensors. Applications in this area will make it possible to repair and 
improve biological systems at the molecular level, as well as monitor biological activities. 
These tasks will be accomplished through the sub-areas of nanoparticle drug delivery, 
nanodiagnostics, and molecular nanotechnology.  
Nanotechnology can start a true revolution in biomedical applications. New types 
of drugs and new drug-delivery techniques have already been designed. Photodynamic 
                                                 
7 Editors of Scientific American, Understanding Nanotechnology, New York: Warner Books, 2002. 
8 Ibid. 
9 Ibid. 
10 Ibid. 
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therapy brings an incredible change in treatments of many diseases by attacking them 
with greater specificity and accuracy11 . This therapy is an alternative technique for 
treating cancer that does not present the deteriorating side effects that are caused by 
chemotherapy12.  
Another revolution with remarkable applications is the molecular motor. These 
devices will make the transportation of drugs and sensors inside the body very efficient 
by delivering drugs to the specific nanoluminescent tagged cells 13 . Neuro-electronic 
interfaces will make possible the activation of receptors and synapses that have been 
disconnected from the brain. These nanodevices will be connected to computers in order 
to maintain and execute the functions that could not be performed by the damaged brain14.  
 
Sensors will play an essential role in the application of nanomedicine. The size of 
such structures will be optimal for medical uses. Biosensors open a whole new window in 
medical practices, changing not only the way we monitor diseases, but also the way we 
identify them. With these machines we can identify many different biological entities 
                                                 
11 Ratner,M. and Ratner D. Nanotechnology: A Gentle Introduction to the Next Big Idea. New Jersey: 
Prentice Hall, 2003. 
12 Ibid. 
13 Ibid. 
14 Ibid. 
15  Picture taken from: www.nanotechnologyinvesting.usimagesnanotechnology-480. 
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starting from proteins and drugs and ending at complex organisms like viruses16. DNA 
sensing is a great tool in medical applications for identifying DNA sequences that are 
unique to a certain bacterium, virus, or genetic diseases. Nanoscientists have developed 
extremely accurate techniques for DNA sensing by designing small molecules that 
change color when they bind to a given DNA sequence. A different class of molecules 
has been used to design electronic noses, which are another type of sensor that function 
similarly to the human sense of smell17.  
Up to date, no mass production of any of the above products has been possible. 
However, intense research in some of the major labs in the world is showing that these 
products are not a mere hope, but can be built in the near future. Having no market 
history, the field of nanomedicine cannot be assessed as profitable or non-profitable. The 
initial success in the market will not only be determined by the effectiveness of the 
products, but also by the way the consumer perceives the product itself. The effectiveness 
of any device can be assessed through scientific analysis and laboratory testing, but the 
perceived risks can only be understood by studying the consumer’s decision-making 
process.  
1.4. PREVIOUS RESEARCH  
In order to achieve this broadly defined goal, this project group investigated the 
existing literature about the human psyche─the process one uses when making a 
decision─and public-acceptance trends of prior technologies. Among the various theories 
that are presented about the processes that people use to form a decision, Dietram A. 
Scheufele and Bruce V. Lewenstein wrote an article entitled, “The public and 
nanotechnology: How citizens make sense of emerging technologies” that proved to be 
influential in our research. The authors referred to the Cognitive Miser versus Scientific 
Literacy theory18. Their research consisted of a phone survey of 704 consumers which 
gathered information about people’s knowledge and attitudes of nanotechnology. The 
                                                 
16 Ratner, M. and Ratner, D. Nanotechnology: A Gentle Introduction to the Next Big Idea. New Jersey: 
Prentice Hall, 2003. 
17 Ibid. 
18 Scheufele, Dietram A. and Lewenstein, Bruce V. “The public and nanotechnology: How citizens make 
sense of emerging technologies.” Journal of Nanoparticle Research. Springer Inc. 2005.7: 659-661. 
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article also identified a key factor that influences how the public views nanotechnology 
and its risks and benefits—media framing19.   
 Sheufele and Lewenstein’s article discusses the theory of Cognitive Misers and 
Scientific Literates as the two existing groups that people fall under when making a 
decision20. Of the two groups, the majority of the public is classified as Cognitive Misers. 
Those who fall under the Cognitive Miser model are characterized as valuing the advice 
of friends and family and being highly influenced by the media’s portrayal of a topic, as 
cognitive misers employ cognitive shortcuts referred to as heuristics 21 . Conversely, 
Scientific Literates value the process of gathering information when making a decision, 
regardless of the topic of interest. These individuals often reference research journals and 
colleagues or persons who are highly knowledgeable in the field. Scientific Literates 
make a decision after they believe enough information has been collected in the topic to 
formulate an educated conclusion22. 
For three successive years, teams of students have been conducting a semester and a 
half Interactive Qualifying Project23 (IQP) on the topic of nanotechnology. The objective 
of the third-year IQP team was to build on the past two IQPs’ research and conclusions. 
The first IQP focused on studying people’s perceptions about the applications of 
nanotechnology in the fields of medicine, materials, and manufacturing24. The research 
showed that people’s acceptance level for the applications of nanotechnology in medicine 
was low. They concluded that people’s acceptance level correlated to how directly they 
were affected by the applications of each field.  
Expanding on the first IQP’s findings, the second IQP group researched three existing 
technologies and their historical trends of public acceptance to find a correlation with 
acceptance trends of nanotechnology25. The technologies studied showed three different 
levels of direct contact with the public: nuclear energy, which represented the least 
                                                 
19 Ibid. 
20 Ibid. 
21 Ibid. 
22 Ibid. 
23 Commonly referred to as an IQP on the WPI campus, this project is a requirement for all students to 
graduate.  
24 Allwood, T., Psiakis, K., Regan, T. WILL PREY CONSUME NANOTECHNOLOGY? IQP 2005. 
Worcester Polytechnic Institute. 
25 Sklyar, A., Smith, J., Stedman II, C. Social Acceptance of Technologies. IQP 2006. Worcester 
Polytechnic Institute. 
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personal contact; genetically modified foods; and vaccination, which represented the 
most personal contact. Their research showed that the perception of risk vs. benefit was 
the most important factor in determining social acceptance of nanotechnology.   
The conclusions from the first and second IQPs showed that nanomedicine was 
the least socially accepted area of nanotechnology and that a very important factor in 
determining its social acceptance was the perception of risk vs. benefit. These findings 
were the principal motivation for focusing this IQP on the public’s social acceptance of 
nanomedicine with an emphasis on the perceived risk versus benefit. 
1.5. PROJECT GOALS  
As stated before, previous research has shown that people’s decision-making 
process is not governed by merely one factor. A plethora of literature proposes that a 
variety of influential parameters exist in the decision-making process for accepting a 
technology. The two parameters of the decision-making process used in this study were 
the Cognitive Miser vs. Scientific Literate Models and the risk behavior of each 
individual. The primary goal of this IQP is to establish the most influential factors on the 
decision-making process for the use of nanomedicine, and secondly to determine the 
correlation between the stated parameters on the decision-making process and the 
acceptance of nanomedicine.  A survey was collected from 250 WPI students to 
accomplish the primary goal of this IQP26. 
In accomplishing the primary goal of this project, we also study the individual’s 
change of acceptance of nanomedicine in the survey. The results obtained from the 
individual’s change of acceptance of nanomedicine can be correlated to each individual’s 
data on the first two aspects of the decision-making process in order to determine their 
correlation.  
Our research might prove beneficial to manufacturing technologists and investors 
in the field of nanomedicine. If nanomedicine specialists knew the key factors which 
people use when evaluating the potential risks and benefits of nanotechnology, their 
public relations techniques could be optimized. This task is of importance to not only 
manufacturing technologies and investors, but to the general public as well. It is 
                                                 
26 See APPENDIX A for the survey.  
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necessary for the public to be accepting of nanomedicine because of the predicted impact 
it will have on the betterment of healthcare. 
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2. METHODOLOGY AND HYPOTHESES  
2.1. TARGET POPULATION  
In order to gather an accurate description of the public’s opinion about 
nanomedicine, the target population needs to be closely defined. In an attempt to 
maintain a high response rate, the determined target public was the Worcester 
Polytechnic Institute (WPI) student body. Nine classes were strategically picked to 
maintain both a good representation of the WPI student body as well as a proper random 
sample, maintaining an accurate male to female ratio and class-year distribution27. WPI’s 
current male and female percentages are 76% and 24% respectively 28 . Also, WPI 
currently has a class-year distribution of 23% seniors, 25% juniors, 26% sophomores, and 
26% freshmen. As suggested from Salant and Dillmans’ book How to Conduct a Survey, 
a 95 percent confidence interval with a five percent sampling error is desired for 
reputable survey results29.  Therefore, for the target population of 2,851 students, the 
recommended sample size would be approximately 250 students30.  
2.2. MODE OF DATA GATHERING  
 Once the desired sample size was determined, the mode of information production 
needed to be determined. Among the various methods of surveying: e-mail, telephone, 
mail, drop-off, and interview, the “drop-off method” was best-suited for the constraints of 
the project (i.e. money, time, population size, etc…). Students of nine classes were 
handed a survey constructed by the IQP team which could be completed in under ten 
minutes.  
2.3. DESCRIPTION OF SURVEY  
The survey 31  was purposely designed to explore the goals of the IQP project. 
Throughout its creation, the document was carefully evaluated for proper surveying 
techniques. Under the guidance of Dr. Doyle, a professor of Psychology at WPI with 
                                                 
27 See APPENDIX B for table of courses surveyed.  
28 www.wpi.edu 
29 Salant,P. and Dillman,D. How to Conduct Your Own Survey. New York: John Wiley & Sons, Inc, 1994. 
30 See APPENDIX C for table of 95% confidence interval. 
31 See APPENDIX A for survey. 
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surveying expertise, and the text, How to Conduct your Own Survey32, the IQP team 
formed a four-paged document, with each question being strategically shaped to further 
investigate a parameter or goal of the survey. Common surveying techniques were 
integrated. For instance, the questions were formulated in a manner that would not 
present any bias. Statements were not worded in a “closed-ended” form, to minimize the 
accuracy of the survey: instead of forcing the respondents to compartmentalize 
themselves by circling “yes” or “no” to a response, the questions were formulated to 
allow the respondents to answer:  “agree”, “disagree” or “not sure.” A specific example is 
seen in Question 16 of Appendix A. 
 The first section of the survey utilized three questions to explore the Cognitive 
Miser vs. Scientific Literate Models, one of the three primary objectives of the survey. 
The questions explored the tendency of the individual to rely on the media to reach a 
conclusion and the other basic decision-making characteristics that were defined in “The 
public and nanotechnology: How citizens make sense of emerging technologies”33. The 
manner that the respondents answered the three questions determined their decision-
making type: cognitive miser or scientific literate. 
 Question 4 of the survey was shaped to define the six most influential factors 
employed when deciding to use a new medicine. Fifteen various factors, including a 
space to list others, were mentioned—ranging from financial reasons, to information on 
the package to family history—and the respondents were asked to circle the five most 
valuable to them when deciding to use a new medicine. 
 Questions 5-15 were created as pairs to formulate a series of five questions to 
explicitly study the respondents’ acceptance of nanomedicine—specifically the likeliness 
of using a medicine containing nanoparticles versus using a new medicine in general. 
Question 5 was paired with 11, question 6 with 12, question 7 with 13, question 8 with 14, 
and question 9 with 15. The respondents were asked to circle the degree of acceptance for 
each question with the aid of a scale ranging from values one to five. Within each of the 
five sets, the questions were framed very similarly; the only difference was one question 
                                                 
32 Salant,P. and Dillman,D. How to Conduct Your Own Survey. New York: John Wiley & Sons, Inc, 1994. 
33  Scheufele, Dietram A. and Lewenstein, Bruce V. “The public and nanotechnology: How citizens make 
sense of emerging technologies.” Journal of Nanoparticle Research. Springer Inc. 2005.7: 659-661. 
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inquired about the likeliness of the respondents to use a new medicine under the 
conditions specified, while the other one included the likeliness of the respondent using a 
new medicine containing nanoparticles. Furthermore, each of the five sets was vigilantly 
constructed to explore one condition alone so as to obtain reliable results. The first set 
studied the likelihood of the respondents’ using a medicine containing nanoparticles that 
would treat an illness with the same efficiency as the existing one. The second set 
explored the financial influence, specifically the effect on the person’s acceptance of a 
nanomedicine if the cost was lower than an existing drug of the same efficiency. Set three 
investigated the likeness of using a nanomedicine if it were more efficient at treating an 
illness than an existing drug. The aspect of using a nanomedicine, in the form of a 
vaccine, while it was still in clinical trails was studied in question set 4. The final set 
inquired about the likeliness of using a nanomedicine based on the fact that a friend or 
family member has had success with. 
The last parameter of the survey to be investigated, risk behavior, was on page 
four with a table listing several activities. Respondents were first asked to rate each 
activity, on a scale of 1-6, for the level of physical risk it posed. Secondly, respondents 
were asked to check all of the activities which they would participate in. This table aimed 
at evaluating the general risk behavior of the respondent as being safe, moderate, or risky. 
The risk-behavior personality was later used to explore a possible correlation between the 
respondent’s acceptance of nanomedicine and his or her risk-behavior personality. 
 For general informational purposes, a section in the center of the survey contained 
a place for the respondent to define his or her sex, major, and class year. These questions 
were necessary to gauge the representation of the sample population and ensure that it 
was an accurate gathering of the WPI student body.  
 Another minor section of the survey contained two questions targeting the degree 
of media usage when deciding to accept a new medicine, and a medicine containing 
nanoparticles. In Appendix A these are questions 10 and 16. 
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2.4. DESCRIPTION OF GRAPHICAL REPRESENTATION OF DATA 
The results of the three parameters investigated by the survey were graphically 
represented in a model of three axes, (x, y, z), as seen in Figure 3. The x-axis holds the 
cognitive misers at one end and the scientific literates at the other. The y-axis represents 
the risk behavior of an individual, with the conservative individuals on one side and the 
risk enthusiasts on the opposite side. The z-axis denotes the individual’s acceptance of 
nanomedicine, with the top presenting those who are accepting of nanomedicine to some 
positive percentage and the bottom representing those who negatively view nanomedicine. 
The respondents will receive a value for each axis and their response distribution will be 
plotted on the axes chain in Figure 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.5. EXPECTED DATA TRENDS  
There are a series of expected trends in the data. One anticipated trend is that the 
results will show a greater percentage of Scientific Literates versus Cognitive Misers 
because the survey was taken only by WPI students. WPI is a technical school and thus is 
attended by students who are interested in scientific topics.  
Another expected trend is that the Scientific Literate individuals might be more 
accepting of nanomedicine since they are in theory more interested in scientific topics 
 
Figure 3: Graphical representations of the three parameters studied 
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and thus more prone to be accepting of a new emerging technology. In contrast, the 
Cognitive Miser individuals might be less accepting of nanomedicine because they are in 
theory individuals who make decisions with less information. This can result in 
producing a greater fear towards accepting an emerging technology such as 
nanomedicine because its benefits and risks might not be understood sufficiently.   
A trend may be present between the acceptance level of nanotechnology and the 
risk behavior of each individual. In general, a risk-driven individual is more prone to be 
accepting and being enthusiastic about the unknown. This attribute could evolve into 
accepting emerging technology, such as nanomedicine. In contrast, a risk-adverse 
individual might be less prone to partake in activities that are unfamiliar. Thus, these 
individuals would be more hesitant to participate in a new technology such as 
nanomedicine.   
Overall, if the results obtained from the survey allow us to determine the most 
influential factors as well as any trends among the two aspects of the decision-making 
process in accepting nanomedicine, valuable conclusions might be made about how to 
achieve a higher social acceptance of nanomedicine.  
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3. RESULTS AND ANALYSIS 
3.1. DESCRIPTIVE RESULTS 
The descriptive results from the survey met a 95% confidence interval with a +/- 
5% sampling error as the sample population size was approximately 250 WPI students34. 
The sample population proved to be a good representation of the WPI population of 2851 
students. The results obtained gave a male and female percentage of 77% and 23% 
respectively, compared to WPI’s current male and female percentages of 76% and 24% 
respectively35. The results showed that the class distribution of the sample population was 
comprised of 13% seniors, 23% juniors, 23% sophomores, 40% freshmen, and 1% high 
school students taking a course at WPI. Currently WPI has 23% seniors, 25% juniors, 
26% sophomores, and 26% freshmen.  
One of the goals of this research was to determine the correlation of the two 
parameters on the acceptance of nanomedicine. The descriptive results for the two 
parameters studied are as follows. The acquired percentages of cognitive misers vs. 
scientific literates were 41% and 59%, respectively. Since WPI is an engineering school, 
a higher percentage of scientific literates was expected. The results for the second 
parameter studied, the population’s risk behavior, consisted of 69% moderate, 23% safe, 
and 8% risky.  
3.2. ANALYSIS  
The average response for each question was also analyzed as part of our initial 
results. Figure 4 shows the averages of related questions plotted next to each other. It can 
be seen from the height of the bars that there is no real significant change from one 
question to the other of the same pair. This is an indication of the fact that our sample 
population is tolerant of nanomedicine: the fact that nanoparticles are introduced in one 
of the questions of the pair, does not change the answer of the respondent. As seen in 
Figure 4, the pairs Q6, Q12, and Q7, Q13 have a higher average than the others. These 
high averages in response are not surprising, since the first pair analyzes the factor of 
                                                 
34 See APPENDIX C for table of 95% confidence interval 
35 www.wpi.edu 
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lower cost medicines and the other pair investigates the use of medicine of higher 
efficiency.  
 
Figure 4: Averages of responses for the five sets of questions 
 
In accomplishing the primary goal of the survey, the acceptance of nanomedicine 
was measured through five sets of questions. The values obtained for the change in 
acceptance of the five sets of questions were a key component of the analysis of the 
survey as they were correlated to the two parameters studied. Question 5 was paired with 
question 11, question 6 with question 12, 7 with 13, 8 with 14, and 9 with 15. For these 
five sets of questions, the respondents were asked to circle a number indicative of their 
degree of acceptance.  
 An average change in acceptance of zero symbolized that including nanoparticles 
in a medicine had no effect on the individual’s decision when compared to today’s 
medicine. In other words, the individual tolerated the nanomedicine, showing no change 
in response when the situation described in each question contained nanoparticles. For a 
change in acceptance value greater than zero, the population preferred the inclusion of 
nanoparticles in today’s medicine; thus, the nanomedicine part of the set of the question 
was more accepted. An average acceptance value less than zero denoted a resistance of 
the respondent to a medicine containing nanoparticles.  
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3.3. CM VS SL AND ACCEPTANCE LEVEL OF NANOMEDICINE 
One aspect of the analysis that was investigated was the correlation between 
acceptance of nanoparticles in medicine and the decision-making type of the individual. 
The predicted trend was that respondents who were found to be scientific literates would 
have a higher tolerance for the inclusion of nanoparticles in medicine than cognitive 
misers. Two graphical representations exist of both cognitive misers and scientific 
literates: the averaged values of each of the five question sets and the difference value for 
the change in acceptance for each responder. The respondent was first placed in either the 
cognitive miser group or scientific literate group before being graphed. The average value 
for each set of the five corresponding questions, ranging from question five to question 
fifteen, for the groups of cognitive misers and scientific literates is seen on Figure 6. As 
shown in Figure 5, graphs of the responses of cognitive misers and scientific literates for 
each of the five corresponding sets of questions were created. As with all the graphs in 
this section, the values graphed from the blue line represent all the cognitive misers’ 
change in acceptance values; the pink data points represent the change in acceptance 
values of scientific literate individuals. 
Unlike Figure 7, which shows a spectrum of the responses for question 11 and 5, 
Figure 6, shows the average change in acceptance value for both cognitive misers and 
scientific literates with respect to each of the five sets of questions. As predicted, the 
average change in acceptance for scientific literates was higher—the value is more 
positive—for each set of questions. However, the magnitude is so small, that no results 
can be obtained to support the IQP team’s prediction. Figure 5 show the same graphical 
display of data points, thus supporting the fact that the change in acceptance is so small 
among the questions. This symbolizes that overall, regardless of the scenario, the sample 
population is tolerant of nanomedicine. 
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The only question that yielded a “positive result” was the first question set, Q11-
Q5; this symbolized a slight social acceptance of the sample population’s wiliness to use 
nanomedicine. Therefore, the respondents ranked themselves higher; they were more 
likely to use “A new medicine containing nanoparticles to treat an illness with the same 
efficiency as an existing medicine (all other characteristics being equal)” when compared 
to the value they selected for likeliness of using a new medicine that was fabricated with 
current production method36.  However, the magnitude of showing overall acceptance of 
this question is so small, less than 0.5 for both decision-making types, showing that there 
is no significant change between the pairs of questions. 
                                                 
36 See APPENDIX A for survey. 
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Figure 6: Average distribution of acceptance for CM and SL 
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 Unexpected results were showed in the third set of questions; it explored the 
public’s acceptance of using a drug containing nanoparticles that was more efficient 
than the existing drugs on the market. Surprisingly, both decision-making types felt the 
least accepting of purchasing medicine containing nanoparticles under the restraints of 
the question set. The cognitive misers were less likely to use the nanoparticle 
containing drug with an average value of acceptance of -.35, while the average 
scientific literate value was -0.2837. Figure 5 shows the distribution of responses for all 
respondents respective to their cognitive miser or scientific literate classification. 
3.4. RISK BEHAVIOR AND ACCEPTACE OF NANOMEDICINE 
A careful analysis of the acceptance of nanomedicine as a function of risk 
behavior reveals a very similar distribution with the acceptance of nanomedicine as a 
function of cognitive and scientific behavior. Furthermore, the three different categories 
of risk behavior have almost identical distributions among themselves as well.  
                                                 
37 See figure 5b for graphical representation. 
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Figure 7: Q11-5 change in acceptance for CM and SL 
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In total we have analyzed 65 safe, 158 moderate, and 27 risky respondents. As 
with the cognitive and scientific types, we examined the change in acceptance for each 
question related to nanomedicine and the overall acceptance level for each question 
pertaining to different factors. For all the questions, it is clear that the distribution in 
answers is the same no matter what the risk behavior is. This is an indication of the fact 
that these different types react in the same way to the factors that each question explores. 
More importantly, this similarity extends for all the five pairs of questions analyzed.  
Questions 11 and 5 both measure the impact of a new medicine that has the same 
efficiency. It is clear from the graph that all three types manifest a similar change in  
 
 
acceptance. The other questions measure the factors of price, efficiency of the medicine, 
clinical trial of vaccines, and friends or family advice. For all these factors, the graph 
above is a good representative of the similarity trend within the same question. In Figure 
9 the following four graphs show the similarity trend not only within the same question, 
but for different questions as well. This trend seems to be universal for both the cognitive 
and risk types. 
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Figure 8: Q11-5 change in acceptance for safe, moderate, and risky 
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 The overall acceptance behavior, measured by the average, also shows a similar 
trend for the three different types. Figure 10 shows that the respondents were accepting 
when the medicine contained nanoparticles and all other factors were left unchanged. As 
soon as another factor was introduced, the respondents became non-accepting, regardless 
of their risk type. It is to be noted that the average values were relatively small, but, 
nevertheless, they represent the measure of the acceptance level. The moderately risky 
respondents were the most accepting in the case when the only change was the fact that 
the medicine is new in the market. The safe respondents were more accepting, and 
surprisingly, the least accepting of using a nanoparticle-containing drug were those 
having risky behavior. When the new medicine was cheaper and containing nanoparticles, 
the moderate respondents went to the other extreme, being the ones that were the most 
denying, followed by the safe and the risky; for Q12-6 respondents having risky behavior 
were the most accepting. The third question pair, Q13-7, focused on a new more efficient 
medicine containing nanoparticles. Under this scenario the safe respondents became the 
most accepting while the risky respondents became the least accepting. In the case of 
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Figure 10: Average acceptance distribution for risk behavior 
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vaccines, Q14-8, the moderate and risky respondents manifested the same degree of 
acceptance, while the safe respondents were the most accepting. Risky respondents were 
the least accepting when they were asked to rate the likeliness of using a medicine with 
nanoparticles that a family member or friend suggests. Safe respondents were most 
accepting. 
When the averages in acceptance vs. the risk and cognitive types were compared,  
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Figure 11: Comparison of average distribution in for risk behavior and CM/SL 
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very similar patterns are apparent, as seen in Figure 11. These similarities could be an 
indication of the fact that acceptance of nanomedicine is universal and does not depend 
on the risk behavior or the cognitive type.  
3.5. GRAPHICAL REPRESENTATION OF DATA 
To have an overall view of our data, they were plotted in a 3D graph shown in Figure 
133, where the x-axis represents the risk behavior, the y-axis the cognitive and scientific 
types, and the z-axis the social acceptance of nanomedicine. To plot the cognitive and 
scientific types a value of -1 was assigned if the responder was a cognitive miser and a +1 
value if the responder was a scientific literate. The overall acceptance of a responder was 
measured by the average of all the differences calculated from the pairs of questions from 
9 to 15. A color code was assigned to the risk behavior types: green symbolizing a risk 
adverse, yellow a moderate, and red signifying a risk enthusiast. The following graphs 
plot the points for all 250 respondents. A 2D projection of our data is first given so that 
the points can be viewed easily. The top graph of Figure 12 shows a perspective view of 
the points. A careful look at the graphs affirms the results obtained from the individual 
graphs above: there is no correlation between cognitive, scientific and risk types with the 
social acceptance of nanomedicine. Furthermore, looking at the acceptance axis (z-axis) 
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Figure 12: 2D projections of data from three angles 
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Figure 13: Two views of complete data 
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it is clear that the data lie very close to the origin, indicating that the sample population is 
more tolerant of nanomedicine. However, for the sake of correctness, the overall average 
of the entire data points is -0.21, a value very close to zero but nonetheless a negative 
value.  
3.6. MOST INFLUENTIAL FACTORS IN ACCEPTING A NEW MEDICINE 
Among the fifteen factors available, six top factors were determined: doctor’s advice, 
clinical research, side effects, FDA approval of the medicine, information on package, 
and research journals, respectively. Figure 14 illustrates the percentages of each of these 
factors that were chosen by the respondents. After the fourth top factor, information on 
package, there was a drop of approximately 50 responses, and after the sixth top factor, 
research journal, a drop of approximately 50 responses occurred. The remaining nine 
factors decreased constantly in the number of times they were chosen. This result proves 
to be insightful, as the ultimate goal was to find the most influential factors for social 
acceptance of nanomedicine.  
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Figure 14: Top six factors for accepting a new medicine 
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4. CONCLUSIONS 
4.1. IMPLICATIONS FOR THE FIELD OF NANOTECHNOLOGY 
 The survey allowed for insight into the decision-making process in acceptance of 
nanomedicine. It was found that there is no correlation between the social acceptance of 
nanomedicine and the cognitive miser and scientific literate models as well as with the 
risk behavior of the respondents. The data distribution for the cognitive misers and the 
scientific literates in correlation to the acceptance level of nanomedicine resulted in the 
same bell curve with the maximum lying on the zero value for the x-axis. This is 
representative of how the inclusion of nanoparticles in medicine has no increase or 
decrease on the likelihood of our target population using that medicine.  This same bell 
curve existed for the three risk behaviors studied in the survey: risky, moderate, and safe 
individuals. The results obtained were not expected, as the theories of the cognitive miser 
and scientific literate models suggested there would be an increase of acceptance of 
nanomedicine for scientific literates and a decrease for cognitive misers. In a similar way, 
it was expected that risky individuals would have an increase in their acceptance of 
nanomedicine, moderates would show no change of acceptance, and safe individuals 
would show a decrease in their acceptance of medicine containing nanoparticles.  
Even though the results show that there is no significant difference on how the 
individual reacts toward the inclusion of nanoparticles in medicine, the fact that the 
average change of acceptance of the 250 individuals surveyed was -0.21 has to be 
discussed. This value has two interpretations: the first being that it is a negative value; 
therefore, it represents the fact that the overall population surveyed was not tolerant of 
nanomedicine. The other being that it is a value very close to zero, which means that the 
population is neither tolerant nor accepting of nanomedicine. In conclusion, since the 
possible differences could range from -4 to 4, a value as close to zero as -0.21 was 
considered to represent that the target population showed no change in acceptance 
between the use of a new medicine containing nanoparticles and a new medicine without 
nanoparticles. It was concluded that a possible cause for such a result could be the fact 
that the survey was conducted in a technical college, where the majority of its students 
  
30 
30 
have a predisposition to be interested in science and its innovations, such as 
nanotechnology and its applications.  
Finally, one very insightful conclusion from the survey was that the most influential 
factors used when determining to use a new medicine were: doctor’s advice, clinical 
research, side effects, FDA approval of the medicine, information on package, and 
research journals. It is evident that the significance of knowing which factors the public 
has articulated as the most influential in their decision-making process for the use of a 
new medicine, serves as being very helpful for marketing strategies. The fact that our 
target population also presented a neutral reaction towards the inclusion of nanoparticles 
in medicine is complementary to the factors that were determined important when 
deciding to use a new medicine, as they can also be applied to public-relations strategies 
for nanomedicine.  
In today’s world, nanotechnology is no longer an innovation of the future; it is of 
great importance to public health that nanotechnology be socially accepted by the general 
population. Thus, determining the factors and parameters that are most influential in the 
acceptance of nanomedicine is of crucial importance to not only manufacturers, investors, 
and researchers, but also the general public.  
 
4.2. RECOMMENDATIONS FOR FUTURE RESEARCH 
 For future IQP teams, it is recommended that the direct role of the media on the 
public be explored thoroughly, as the two questions, questions 10 and 16 which directly 
targeted this relationship, were found inconclusive. The vast majority of the respondents’ 
data to these questions denied any influence of advertising towards swaying their 
decision to use a new medicine. However, due to a known journalism tactic called “media 
framing,” a case could be created to argue the importance of the media’s role for 
achieving social acceptance of nanomedicine.  Therefore, it is advised that the data from 
the 250 respondents be employed to propel this investigation. 
 Also, since the current IQP team had only three weeks to analyze all the data the 
survey provided, it is suggested that the next IQP team delve deeper into the respondents’ 
answers and search for other possible findings that the data have to offer. Perhaps, other 
connections can be made, since no conclusive correlations between the Cognitive Miser 
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and Scientific Literacy Models and an individual’s risky behavior to the public’s 
acceptance of nanomedicine could be reached. 
 The chief recommendation for next year’s team is to distribute this survey to 
Clark University students and compare the results both between the sample populations’ 
social acceptance. Since WPI is a technical school, it is suspected that social acceptance 
of nanomedicine would be higher than in a university attended by diverse individuals of 
various liberal arts and technical majors.  If the results could be compared, perhaps a 
relationship among the parameters would be observable, and a more thorough 
understanding of the public’s acceptance of nanomedicine would be possible, at least for 
college populations.   
 Besides IQP members, others can benefit and build on the results of the 2006-
2007 IQP project. Technological manufacturers, scientists, and investors in nanomedicine 
can recognize the public’s articulated influence by doctor’s advice, clinical research, side 
effects, FDA approval, information on package, and research journal, in order of 
importance. Specifically, personnel in the field of media can capitalize on the knowledge 
of these important factors and design medical packaging and subsequent advertising to 
knowingly include these aspects. Uncovering the needs of the public for accepting the 
various areas of nanotechnology is beneficial to persons in various areas of work. Thus, it 
is imperative to continue the investigation of social factors influencing the decision-
making process of emerging technologies.  
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6. APPENDIXES  
6.1. APPENDIX A: SURVEY 
Please answer the following four questions so that we can learn about your decision-
making process.  
 
1. When you bought your last computer which resource did you use to help you 
decide? (Please circle one option) 
A friend who has used it 
Research journal 
Family member 
Product website 
Other (please specify): ____________ 
 
2. Rank the following resources you use when gathering information about a 
new technology? (Rank) 
1=most important   6=least important 
 A research journal 
 News  
 T.V commercials 
 A friend 
 Educational/Scientific TV programs 
 Library/Online database 
 
3. How often did you read the “Science and technology” section of the newspaper 
(hard copy or online) over the past 2 months? (Please circle) 
1 Never  
2  Less than half the time  
3  Half the time  
  
34 
34 
4  More than half the time  
5  Always 
 
4. Of the following factors which would you consider the five most important when 
deciding to use a new medicine? (Please Circle) 
• Relative’s advice 
• Research Journals 
• Side effects 
• Friend’s advice 
• Advertisement  
• Clinical results  
• Information on the 
package 
• Doctors’ advise 
• Company producing 
the medicine 
• Equivalent 
medicines 
 
• Financial 
• Magazines 
• Religious 
• FDA approved 
• Family history 
• Other(s):_________
Please provide this basic information about yourself 
A. Male Female (Please circle) 
B. Major(s): _______________ 
C. Class Year: ________ 
 
Please answer questions 5-10 which pertain to the factors that are important to you when 
using or buying a new medicine.   
 
5. If there were a new medicine to treat an illness with the same efficiency as an 
existing medicine (all other characteristics being equal), how likely would you be 
to use the new medicine? (Please circle) 
 
Not at all 1 2 3 4 5 Very likely 
 
6. If there were a new medicine that treats an illness and it were cheaper than an 
existing medicine (all other characteristics being equal), how likely would you be 
to buy the new medicine? (Please circle) 
 
Not at all 1 2 3 4 5 Very likely 
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7. If there were a new medicine that treats an illness more efficiently than the 
existing medicine (all other characteristics being equal), how likely would you be 
to use the new medicine? (Please circle) 
 
Not at all 1 2 3 4 5 Very likely 
 
8. How likely would you be to use a vaccine to acquire immunity against a life 
threatening disease while it is still in clinical trials? (Please circle) 
 
Not at all 1 2 3 4 5 Very likely 
 
9. How likely would you be to use a new medicine that a close friend or family 
member has had success with and suggests to you? (Please circle) 
 
Not at all 1 2 3 4 5 Very likely 
 
10.  How often do you rely on advertisements when deciding to use a new medicine? 
(Please circle) 
 
Never 1 2 3 4 5 Every time 
   
Please answer questions 11-16 which pertain to the application of 
nanotechnology in the field of medicine. The following definitions are given to help you 
answer the following questions with a basic knowledge about nanotechnology and 
nanomedicine. 
Nanotechnology is a branch of technology that is concerned with devices that 
have nanometer size. A nanometer is 1 billionth of a meter. Take one centimeter and 
divide it in ten million equal parts and pick one of those parts: that is one nanometer. 
Nanoparticles are any nanometer size particles that are used in nanotechnology to 
perform a desired function. The application of nanotechnology in the field of medicine 
uses such nanoparticles, and is termed nanomedicine.  
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11. If there were a new medicine containing nanoparticles to treat an illness with the 
same efficiency as an existing medicine (all other characteristics being equal), 
how likely would you be to use the new medicine? (Please circle) 
 
Not at all 1 2 3 4 5 Very likely 
 
12. If there were a new medicine containing nanoparticles that treats an illness and 
it were cheaper than an existing medicine (all other characteristics being equal), 
how likely would you be to buy the new medicine? (Please circle) 
 
Not at all 1 2 3 4 5 Very likely 
 
13. If there were a new medicine containing nanoparticles that treats an illness  
more efficiently than the existing medicine (all other characteristics being equal), 
how likely would you be to use the new medicine? (Please circle) 
 
Not at all 1 2 3 4 5 Very likely 
 
14. How likely would you be to use a vaccine containing nanoparticles that would 
provide immunity against a life threatening disease while it is still in clinical 
trials? (Please circle) 
 
Not at all 1 2 3 4 5 Very likely 
 
15. How likely would you be to use a new medicine containing nanoparticles that a 
close friend or family member has had success with and suggests to you?   
(Please circle) 
 
Not at all 1 2 3 4 5 Very likely   
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16. Do you agree or disagree with the following statement: “I would rely on 
advertisements when deciding to use a new medicine containing nanoparticles”. 
(Please circle) 
 
Agree  Disagree  Not Sure 
Circle the appropriate number to the right of each of the following activities to indicate 
their level of physical risk. In the column to the far right please check off the activities 
that you would participate in. Please refer to the “Physical Risk Scale” below.
38
 
 
Physical Risk Scale  
No Physical Risk                 1 2 3 4 5 6                 Extreme Physical Risk                                                               
 
                                                                                                 
 Activity Physical Risk Scale 
Check if you 
would 
participate 
1 Water skiing 1 2 3 4 5 6  
2 Eating fatty 
foods 
1 2 3 4 5 6  
3 Parachute 
jumping 
1 2 3 4 5 6  
4 Going on a 
picnic 
1 2 3 4 5 6  
5 Scuba diving 1 2 3 4 5 6  
6 Driving 
recklessly 
1 2 3 4 5 6  
7 Rock climbing 1 2 3 4 5 6  
8 Bungee 1 2 3 4 5 6  
                                                 
38 Physical risk scale was adopted from a previous scale designed by Dr. David J. Llewellyn which can be 
found in http://www.risktaking.co.uk/resources.htm. 
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Jumping 
9 Using 
hallucinogenic 
drugs 
1 2 3 4 5 6  
10 White water 
kayaking 
1 2 3 4 5 6  
11 Smoking 
cigarettes 
1 2 3 4 5 6  
12 Having 
unprotected sex 
1 2 3 4 5 6  
13 Not exercising 
regularly 
1 2 3 4 5 6  
14 Drinking until 
you pass out 
1 2 3 4 5 6  
15 Horseback 
riding 
1 2 3 4 5 6  
 
Please remember to check off the activities that you would participate in. 
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6.2. APPENDIX B: TABLE OF COURSES SURVEYED 
Date 
Time 
and 
Location 
Professor Course 
Number 
of 
Students 
Partners 
Attending 
Number of 
Surveys 
Completed 
Surveys 
Excluded
39
 
Surveys 
Tues.11/28 
9:20 am 
OH 223 
Burnham  
Inter. 
Mechanics 
II 
38 
Nathalia 
Ergys 
33 1 32 
Thurs.11/30 
11:00 am 
OH 107 
Arguello  
Biochem. 
II 
68 
Nathalia 
Ergys 
33 4 29 
Fri. 12/1 
10:00 am 
SL 123 
Manzari 
Inter. Span. 
II 
25 Kate 16 1 15 
Mon. 12/4 
11:00 am 
OH 223 
Mott 
Intro. to 
Literature 
25 Ergys 10 0 10 
Mon. 12/4 
1:00 pm 
HL 218 
Doyle 
Social 
Psychology 
56 
Kate 
Ergys 
37 1 36 
Tues. 12/5 
9:00 am 
DH 
Heinricher Calculus II 13 
Nathalia 
Kate 
13 0 13 
Tues. 12/5 
4:00 pm 
WB 229 
Oliveira 
Calculus 
IV 
35 
Kate 
Nathalia 
Ergys 
45 4 41 
Thurs. 1/25 
1:00 pm 
FL 311 
Riviera  Spanish  40 Kate 35 4 31 
Mon. 1/22 
3:00 pm 
FL 320 
Ciaraldi 
Webware 
CS 
54 Nathalia 45 2 43 
Total 267 17 250 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
39 Data from excluded surveys were incomplete or unusable from one or more of the primary aspects 
studied.  
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6.3. APPENDIX C: TABLE OF 95% CONFIDENCE INTERVAL 
Population 
Size 
+/- 3% sampling 
error 
+/- 5% sampling 
error 
+/- 10% sampling 
error 
- 
50/50 
Split 
80/20 
Split 
50/50 
Split 
80/20 
Split 
50/50 
Split 
80/20 
Split 
750 441 358 254 185 85 57 
1000 516 405 278 198 88 58 
2,500 748 537 333 224 93 60 
5,000 880 601 357 234 94 61 
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6.4. APPENDIX D: IN-DEPTH DESCRIPTION OF SURVEY ANALYSIS 
Cognitive Miser vs. Scientific Literate Evaluation 
The determination of the decision-making type (cognitive miser or scientific literate) 
was decided with the aid of the first two questions of the survey. Question one, as seen 
below, consists of options one and three as being cognitive miser responses. If the 
respondent circled option two or four they would be deemed as a scientific literate for 
this question. 
  
1. When you bought your last computer which resource did you use to help you 
decide? (Please circle one option) 
A friend who has used 
it 
Research journal 
Family member 
Product website 
Other (please specify): 
_______________ 
 
For any “other” responses the article, “The public and nanotechnology: How 
citizens make sense of emerging technologies” would be referenced.  
 
 Next the IQP team recorded the response of question two, as seen below. 
 
2. Rank the following resources you use when gathering information about a new 
technology? (Rank) 
 
1=most important   6=least important 
 A research journal 
 News  
 T.V commercials 
 A friend 
 Educational/Scientific 
TV programs 
 Library/Online database 
 
 
The top answer, the resource which was ranked number one, determined the 
decision-making type of question two. Next the decision-making types for both questions 
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were compared. If the person received two of the same decision types—either both 
questions resulted in cognitive miser or scientific literate—the individual was considered 
automatically considered that type. However, if question one and two yielded different 
decision-making types, further investigation was needed.  The IQP team then referred to 
the top three resources of question two and used that averaged type as the individual’s 
recorded decision type. 
Although three questions existed to determine the decision-making type of the 
respondents, the third question was exempted from the evaluation process. The majority 
of the individuals responded by circling the same choice; therefore, no conclusive 
evidence could be extrapolated from the question.  
 
Risk Behavior Evaluation 
 The risk behavior of each individual was decided from the responses in the last 
question of the survey, located on page three. The respondents’ were asked to circle the 
degree of physical risk each activity contained, on a scale from one to six, and check all 
the activities that they would partake in. For each respondent, the IQP team took the 
activities that the respondent “checked off” and found the average risk behavior of the 
activities. This value was then compared to a determined scale where 1- 2.67 symbolized 
the person as being safe, an averaged value of 2.68- 4.34 was moderate, and 4.35-6.01 
denoted the individual as being risky.  
 
Key of Risk Behavior 
S M R 
1 - 2.67 2.68 - 4.34 4.35 - 6.01 
 
The key was determined by taking the differences of possible averages—they ranged 
from one to six—and dividing by three. This difference was about 1.67; therefore, the 
interval for each risk behavior type needed to be 1.67 units of magnitude.  
 
 
 
